Abstract:Exosome-based liquid biopsy holds great potential in monitoring tumor progression. Current exosome detection biosensors rely on signal amplification strategies to improve sensitivity; however, these strategies pay little attention to manipulating the number of signal reporters, limiting the rational optimization of the biosensors. Here, we have developed a modularized surface-enhanced Raman spectroscopy (SERS) labeling strategy, where each Raman reporter is coupled with lysine as a signal-lysine module, and thus the number of Raman reporters can be precisely controlled by the modularized solid-phase peptide synthesis. Using this strategy, we screened out an optimum Raman biosensor for ultrasensitive exosome detection, with the limit of detection of 2.4 particles per microliter. This biosensor enables a successful detection of the tumor with an average diameter of approximately 3.55 mm, and thus enables successful surveillance of the postoperative tumor recurrence in mice models and distinguishing cancer patients from healthy subjects. Our work provides a de novo strategy to precisely amplify signals toward a myriad of biosensor-related medical applications.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acssensors.1c00890.Experimental details; preparation and characterization of exosomes (Figure S1); preparation and characterization of compound 1 (Figure S2); characterization of the EpCAM aptamer carrying single Raman reporter (Figure S3); detection of A549 cells derived exosomes by SERS EpCAM-aptasensors carrying single Raman reporter and SERS random sequence-sensors carrying single Raman reporter (Figure S4); mass spectra of signal amplified parts carrying (a) 5, (b) 8, and (c) 10 Raman reporters (Figure S5); gel electrophoresis image for EpCAM aptamer carrying eight Raman reporters (Figure S6); quantitative analysis of A549 cell-derived exosomes by ELISA (Figure S7); linear range of exosome detection in plasma by SERS EpCAM-aptasensors carrying eight Raman reporters (Figure S8); stability of the SERS EpCAM-aptasensors for plasma exosome detection (6.00 × 107/mL) in three consecutive weeks (Figure S9); and correlation of the SERS signal with the tumor size of NSCLC mice models (Figure S10). Tables S1–S5 (PDF)This article has not yet been cited by other publications.

Size Matters: Curvature and Antigen-Mediated Dual Recognition of Size-Specific Tumor-Derived Exosomes

Precise Capture and Direct Quantification of Tumor Exosomes via a Highly Efficient Dual-Aptamer Recognition-Assisted Ratiometric Immobilization-Free Electrochemical Strategy.

Accurate Cancer Diagnosis and Stage Monitoring Enabled by Comprehensive Profiling of Different Types of Exosomal Biomarkers: Surface Proteins and Mirnas

Thermophoretic Aggregation Imaging of Tumor-Derived Exosomes by CRISPR-Cas13a-Based Nanoprobes

Exosomes and Microvesicles: Identification and Targeting by Particle Size and Lipid Chemical Probes.

Profiling the size-dependent heterogeneity of membrane proteins in a mixed population of small extracellular vesicle for potential cancer diagnosis

Visual and Fluorescence Dual Mode Platform for Sensitive and Accurate Screening of Breast Carcinoma

Selective detection of exosomes by elemental labeling ICP-MS based on cholesterol-EpCAM aptamer proximity ligation mediated MNAzyme assembly

A smart TESTER for reliable discrimination of cancer-derived small extracellular vesicles

Rapid On-Chip Isolation of Cancer-Associated Exosomes and Combined Analysis of Exosomes and Exosomal Proteins.

Dual-Recognition Triggered Proximity Ligation Combined with a Rolling Circle Amplification Strategy for Analysis of Exosomal Protein-Specific Glycosylation.

CRISPR-based dual-aptamer proximity ligation coupled hybridization chain reaction for precise detection of tumor extracellular vesicles and cancer diagnosis

CRISPR/Cas12a and aptamer-chemiluminescence based analysis for the relative abundance determination of tumor-related protein positive exosomes for breast cancer diagnosis

Colorimetric aptasensor based on spherical nucleic acid-induced hybridization chain reaction for sensitive detection of exosomes

Correlation Between Membrane Proteins and Sizes of Extracellular Vesicles and Particles: A Potential Signature for Cancer Diagnosis.

Ultrasensitive Exosome Detection by Modularized SERS Labeling for Postoperative Recurrence Surveillance

Size-exclusion Chromatography-Based Extracellular Vesicle Size Subtyping and Multiplex Membrane Protein Profiling for Differentiating Gastrointestinal Cancer Prognosis.

Dual signal Amplification-Mediated Aptamer-Based electrochemical biosensor for sensitive detection of exosomes

Multiple and Sensitive SERS Detection of Cancer-Related Exosomes Based on Gold-Silver Bimetallic Nanotrepangs.

Fast and specific enrichment and quantification of cancer-related exosomes by DNA-nanoweight-assisted centrifugation

Branched hybridization chain reaction and tetrahedral DNA-based trivalent aptamer powered SERS sensor for ultra-highly sensitive detection of cancer-derived exosomes